Protein Plus: Improving Infant Growth Through Diet and Enteric Health

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

5,283

Participants

Timeline

Start Date

September 23, 2018

Primary Completion Date

March 19, 2020

Study Completion Date

March 24, 2020

Conditions
StuntingMalnutrition; ProteinEnteric PathogensCampylobacter Infections
Interventions
DRUG

Azithromycin Oral Product

Azithromycin oral suspension (10 mg/kg; 3 days) administered by study personnel at 6 and 9 months of age

DRUG

Placebos

Contain inert excipients only

DIETARY_SUPPLEMENT

Protein Supplement

Blended food providing 125 kcal and 10 g protein as egg white powder prepared as porridge and fed daily to infants from 6-12 months of age

DIETARY_SUPPLEMENT

Isocaloric Supplement

Blended food providing 125 kcal and 1 g protein as rice powder prepared as porridge and fed daily to infants from 6-12 months of age

DIETARY_SUPPLEMENT

Egg

Egg provided daily to infants from 6-12 months of age

BEHAVIORAL

Nutrition Education

Monthly messaging on infant and young child feeding

Trial Locations (1)

Unknown

JiVitA Maternal and Child & Nutrition Research Site, Gaibandha

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03683667 - Protein Plus: Improving Infant Growth Through Diet and Enteric Health | Biotech Hunter | Biotech Hunter